SpringWorks Therapeutics, Inc.

NASDAQ:SWTX

35.35 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 59.73321.0065.4475.5865.8285.5575.7990.8380.3480.00500.1210.170.233500000000000
Kosten van de omzet 3.2971.9310.960.9330.8330.5390.5410.4980.4770.380.1460.3620.360.367000000000000
Brutowinst 56.43619.0754.4874.6534.9955.0185.2580.34-0.129-0.375-0.146-0.241-0.19-0.1373500000000000
Brutowinstmarge 0.9450.9080.8240.8330.8570.9030.9070.406-0.371-750-1.992-1.118-0.596100000000000
Onderzoek- en ontwikkelingskosten 44.36253.62243.65237.45335.85833.52437.92836.06738.02434.10329.34422.86632.09117.37515.26213.92312.9479.72712.17210.74511.2058.4233.7063.4061.3931.393
Algemene en administratieve kosten 57.83960.11359.83646.54646.99444.17540.52635.67330.98727.36626.45218.02914.9312.3818.5197.6696.8746.4035.1994.5843.6463.2652.7411.8242.0142.014
Verkoop- en marketingkosten -0.844-0.729000000000000000000000000
Verkoop-, algemene en administratieve kosten 56.99559.38459.83646.54646.99444.17540.52635.67330.98727.36626.45218.02914.9312.3818.5197.6696.8746.4035.1994.5843.6463.2652.7411.8242.0142.014
Overige kosten 000.373-0.076-0.098-0.1990.153-0.074-0.024-0.193-0.056-0.058-0.0410.003000000000000
Bedrijfskosten 101.357113.006103.48883.99982.85277.69978.45471.7469.01161.46955.79640.89547.02129.75623.78121.59219.82116.1317.37115.32914.85111.6886.4475.233.4073.407
Bedrijfsresultaat -44.921-93.931-98.463-83.999-82.852-77.699-78.454-71.74-69.011-61.469-55.796-40.895-47.021-29.75611.219-21.592-19.821-16.13-17.371-15.329-14.851-11.688-6.447-5.23-3.407-3.407
Bedrijfsresultaat ratio -0.752-4.472-18.077-15.037-14.216-13.982-13.529-85.609-198.307-12,293.80-337.975-276.594-129.3740.32100000000000
Totaal overige inkomsten en kosten netto 5.0026.546-1.462-1.14.9274.2794.276-0.648-0.411-0.53-0.357-0.325-0.2-0.258-0.121-0.13-0.229-0.1-0.113-2.5011.0040.2790.2280.2260.1120.112
Inkomen voor belasting -39.919-87.385-94.322-79.437-77.925-73.42-74.178-72.388-69.05-61.801-56.072-41.041-47.01-29.78711.272-21.659-19.893-15.294-16.217-16.833-13.847-11.409-6.219-5.004-3.295-3.295
Inkomen voor belasting ratio -0.668-4.16-17.316-14.221-13.371-13.212-12.792-86.382-198.42-12,360.20-339.182-276.529-129.5090.32200000000000
Belastingkosten 00.686-5.603-5.662-0.382-4.279-4.276-0.912-0.372-0.198-0.081-0.179-0.211-0.227-0.174-0.063-0.157-0.936-1.267-0.997000000
Nettowinst -39.919-87.385-94.322-79.437-77.925-69.141-69.902-71.476-69.05-61.801-56.072-41.041-47.01-29.78711.272-21.659-19.893-15.294-16.217-16.833-13.847-11.409-6.219-5.004-3.295-3.295
Nettowinstmarge -0.668-4.16-17.316-14.221-13.371-12.442-12.054-85.294-198.42-12,360.20-339.182-276.529-129.5090.32200000000000
WPA (Winst Per Aandeel) -0.54-1.18-1.28-1.27-1.25-1.11-1.12-1.35-1.41-1.26-1.15-0.84-0.97-0.620.3-0.51-0.47-0.37-0.38-1.77-0.33-0.51-0.28-0.23-18.8-18.8
Verwaterde WPA -0.54-1.18-1.28-1.27-1.25-1.11-1.12-1.35-1.41-1.26-1.15-0.84-0.97-0.620.3-0.51-0.47-0.37-0.38-1.77-0.33-0.51-0.28-0.23-18.8-18.8
EBITDA -44.077-93.202-97.925-83.505-82.852-77.446-78.199-71.528-68.821-61.361-55.65-40.776-46.906-29.64611.329-21.497-19.747-16.06-17.306-15.266-14.808-11.667-6.439-5.227-3.404-3.404
EBITDA ratio -0.738-4.437-17.978-14.949-14.216-13.937-13.485-85.356-197.761-12,272.20-336.992-275.918-128.8960.32400000000000